» Articles » PMID: 31308922

Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients

Overview
Date 2019 Jul 17
PMID 31308922
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mutations in the S gene (HBsAg), pre-core (PC), and basic core promoter (BCP) of the hepatitis B virus (HBV) infection are correlated with disease progression. This study assessed the frequency of mutations in the S gene, PC, and BCP regions in chronic hepatitis B (CHB) patients.

Methods: 104 formerly known CHB patients who visited Tehran Hepatitis centers, were included. The viral load of samples was determined based on the TaqMan method. Regions of the S gene, PC and BCP were amplified by the nested PCR. Positive PCR products were sequenced and analyzed.

Results: 33 successfully sequenced S gene region revealed all the derived strains were genotype D, with the majority (90.9%) belonging to the ayw2 subtype, and the rest (9.1%) to the ayw1 subtype. The prevalence of mutations was found to be 51.0% and 18.0% in the HBsAg and the Major Hydrophilic Region, respectively. 70.0% of amino acid changes within HBsAg occurred in different immune epitopes, of which 27.0% and 72.0% were located in B cell and Th epitopes, respectively. 26 successfully sequenced PC and BCP regions showed at least one mutation in 84.6% of the HBV strains. The PC and BCP mutations were G1896A (61.0%), G1899A (23.0%), A1762T/G1764A (23.0%) and G1764T/C1766G (26.0%). None of the strains with A1762T/G1764A mutation carried the G1764T/C1766G mutant.

Conclusions: Our results showed common mutations within HBsAg, occurring in immune epitopes, a high rate of G1896A mutations in the PC region, and a negative correlation between the emergence of A1762T/G1764A mutation and the G1764T/C1766G mutant in the BCP region.

References
1.
Kramvis A, Kew M . The core promoter of hepatitis B virus. J Viral Hepat. 1999; 6(6):415-27. DOI: 10.1046/j.1365-2893.1999.00189.x. View

2.
Chan H, Leung N, Hussain M, Wong M, Lok A . Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology. 2000; 31(3):763-8. DOI: 10.1002/hep.510310330. View

3.
Hunt C, McGill J, Allen M, Condreay L . Clinical relevance of hepatitis B viral mutations. Hepatology. 2000; 31(5):1037-44. DOI: 10.1053/he.2000.6709. View

4.
Bozdayi A, Bozkaya H, Turkyilmaz A, Saryodlu M, Cetinkaya H, Karayalcin S . Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J Clin Virol. 2001; 21(1):91-101. DOI: 10.1016/s1386-6532(01)00148-2. View

5.
Yoo B, Park J, Kim H, Lee D, Cha Y, Park S . Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2002; 38(1):98-103. DOI: 10.1016/s0168-8278(02)00349-5. View